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OBJECTIVES The aim of this study was to determine which clinical, exercise and thallium variables can aid
in the identification of three-vessel or left main coronary artery disease (3VLMD) in patients
with one abnormal coronary territory (either a reversible or fixed defect) on exercise thallium
testing and to test the prognostic value of these variables.
BACKGROUND Although the sensitivity of detection of coronary artery disease by thallium-201 imaging is
high, the actual detection of 3VLMD by thallium tomographic images alone is not optimal.
METHODS A multivariate model for prediction of 3VLMD was developed from several clinical, exercise
and thallium-201 variables in a training population of 264 patients who had one abnormal
coronary artery territory on exercise thallium testing and had undergone coronary angiogra-
phy. Using this model, patients were stratified into risk groups for prediction of 3VLMD. A
separate validation cohort of 474 consecutive patients who were treated initially with medical
therapy and who had one abnormal coronary territory were divided into identical risk
groupings by the variables derived from the training population, and they were followed for
a median of 7.0 years to evaluate the prognostic value of this model.
RESULTS The prevalence of 3VLMD was 26% in the training population despite one abnormal
thallium coronary territory. Four clinical and exercise variables—diabetes, hypertension,
magnitude of ST segment depression, and exercise rate-pressure product—were found to be
independent predictors of 3VLMD. In the training population, the prevalence of 3VLMD in
low-, intermediate- and high-risk groups was 15%, 22% and 51%, respectively. When the
multivariate model was applied to the validation population, the eight-year overall survival
rates in the low-, intermediate- and high-risk groups were 89%, 73% and 75%, respectively
(p , 0.001).
CONCLUSIONS A substantial proportion of patients with one abnormal thallium coronary territory have
3VLMD with subsequent divergent outcomes based upon risk stratification by clinical and
exercise variables. Consequently, the finding of only a single abnormal coronary territory by
thallium-201 perfusion imaging does not necessarily confer a benign prognosis in the absence
of consideration of nonimaging variables. (J Am Coll Cardiol 2000;35:335–44) © 2000 by
the American College of Cardiology
Identifying the presence of a disease by a diagnostic test is
not equivalent to predicting the severity of the disease.
Although the sensitivity for the detection of coronary artery
disease (CAD) in patients with three-vessel or left main
disease (3VLMD) by exercise perfusion imaging is exceed-
ingly high, the actual prediction that such anatomy is
present in a particular patient can be suboptimal if based on
perfusion images alone (1–11). A prior study has shown that
only 29% of patients with three-vessel CAD had three
abnormal thallium coronary territories, but exercise and
clinical variables added significant independent information
to perfusion imaging for predicting the presence of
3VLMD (8). Because revascularization in a substantial
proportion of patients with 3VLMD will decrease mortality
(12–15), identification of these patients can have a beneficial
impact on outcome. Consequently, the prediction of
3VLMD has important clinical implications.
The aim of this study was to develop a model based upon
clinical and exercise variables that could aid in the detection
of 3VLMD in patients who had perfusion scans with only a
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single abnormal coronary territory. This model was devel-
oped from a cohort of such patients who underwent
coronary angiography and applied to a second population of
such patients to predict subsequent mortality and cardiovas-
cular events. This approach assumes that patients with
3VLMD are more likely to have subsequent cardiac events.
METHODS
Study population. The study population consisted of a
training cohort and a validation cohort. The training cohort
was comprised of a consecutive series of 264 patients with
suspected or known CAD who had exercise (following the
Bruce or Naughton protocols) thallium-201 scintigraphy
done at the Mayo Clinic between January 1987 and De-
cember 1989. All patients had only one abnormal coronary
territory by exercise thallium imaging (either a reversible or
fixed defect), and had coronary angiography within six
months of the exercise thallium test. There were 4,481
patients who underwent exercise thallium testing during
this time and 1,602 had one abnormal coronary territory
(36%). Exclusion criteria were as follows: 1) left bundle
branch block, preexcitation syndrome on the resting elec-
trocardiogram or permanent pacemaker; 2) valvular, con-
genital or cardiomyopathic disease; 3) previous coronary
revascularization by either percutaneous transluminal coro-
nary angioplasty (PTCA) or coronary artery bypass grafting
(CABG); 4) any intervening cardiac events (revasculariza-
tion procedure, myocardial infarction) between the two
studies; 5) digoxin use within two weeks of the exercise
study; and 6) technically inadequate perfusion study. The
final training population consisted of 264 patients.
In an effort to avoid the referral bias inherent in studying
a population of patients referred for coronary angiography,
a second population was studied for outcomes. The valida-
tion sample consisted of a separate group of 474 consecutive
patients who had one abnormal coronary territory by exer-
cise thallium-201 tomographic imaging at the Mayo Clinic
between January 1988 and August 1989. Referral to cardiac
catheterization was not an inclusion or exclusion criteria in
this group of patients. Exclusion criteria were identical to
the training cohort.
Clinical data concerning cardiac history and physical
examination for all patients were obtained prospectively
before testing and entered into a laboratory database.
Diabetes was defined as a fasting glucose level .140 mg/dl,
or chronic use of insulin or oral hypoglycemic agents and
analyzed by insulin and noninsulin use. Hypertension was
defined as a systemic blood pressure .140/90 mm Hg on
repeated measurements, or the chronic use of antihyperten-
sive medication (defined as treated hypertension). Hyper-
cholesterolemia was defined as a total cholesterol level
.250 mg/dl or chronic use of a cholesterol-lowering agent.
Treadmill exercise testing. All patients underwent
symptom-limited treadmill exercise testing using either the
Bruce or Naughton protocol (see Table 1 for percentages).
For patients performing the Naughton protocol, a conver-
sion factor was applied to equate exercise duration with the
Bruce protocol (16). Twelve-lead electrocardiography and
heart rate were recorded at rest, every minute during
exercise, at the peak of exercise and every 3 min of recovery.
Maximum ST depression was defined as the maximum
change of ST-segment depression at 80 ms after the J point
during or after exercise. Maximum ST depression was
categorized into groups: ,1.0 mm, 1.0 mm to 1.4 mm,
1.5 mm to 1.9 mm, 2.0 mm to 2.4 mm and .2.4 mm.
Systemic blood pressure was recorded by cuff sphygmoma-
nometry before exercise, at the end of each stage and at peak
exercise. At peak exercise, 4 mCi of thallium-201 were
injected intravenously and patients were encouraged to
exercise for another minute (this study preceded the intro-
duction of thallium reinjection into our laboratory).
Single-photon emission computed tomography (SPECT)
imaging. Images were acquired while the patient was in the
supine position, using a large field-of-view, single-crystal,
rotating gamma camera (Elscint 409) with an all-purpose,
parallel hole collimator and previously described methodol-
ogy (8). A single 5-min anterior planar image was started at
5 to 10 min postinjection to assess cardiac size and pulmo-
nary activity. Tomographic imaging was then performed
from 45° right anterior oblique to 45° left posterior oblique,
using the step-and-shoot method over a 180° arc; 30 images
were obtained at 6° intervals for 40 s each. Each projection
was corrected for nonuniformity, and filtered-back projec-
tion was performed with a Ramp-Hanning filter. Orthog-
onal images were generated by oblique angle reconstruction
producing horizontal long-axis, short-axis and vertical
long-axis slices that were each 6 mm thick. Redistribution
thallium images were acquired in a similar fashion 4 h
postexercise without reinjection of thallium.
Visual analysis of tomographic images. Two experienced
observers interpreted the tomographic images qualitatively
by consensus. Cardiac enlargement and pulmonary uptake
were assessed qualitatively as present or absent from the
anterior planar image. Pulmonary uptake was quantified in
borderline cases (8). Uptake was considered to be elevated if
the pulmonary/myocardial counts were .0.5. Short-axis
images at the apex, middle and base of the left ventricle were
divided into anterior, septal, inferior and lateral segments.
Abbreviations and Acronyms
CABG 5 coronary artery bypass grafting
CAD 5 coronary artery disease
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary
angioplasty
SPECT 5 single-photon emission computed
tomography
3VLMD 5 three-vessel or left main disease
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The septal segments of middle and basal slices were further
divided into anterior and inferior portions (Fig. 1). Conse-
quently, the left ventricle was divided into 14 short-axis
segments as previously described (17). Each segment was
assessed with a 5-point scoring system (4 5 normal perfu-
sion; 3 5 mild, 2 5 moderate, 1 5 severe hypoperfusion;
0 5 absent perfusion). A reversible defect was defined as $1
grade improvement in any segment on the delayed image
when compared to the stress image. A fixed defect had to be
of at least moderate hypoperfusion (grade 2) to be classified
as abnormal. Mild fixed defects were considered normal,
likely reflecting soft tissue attenuation artifacts.
The 14 short-axis segments were assigned to three coronary
territories as demonstrated in Figure 1. Defects at the middle
and base of left ventricle were classified according to the
vascular territories of the three major coronary arteries: anterior
and anteroseptal defects represented disease in the left anterior
descending artery, inferior and inferoseptal defects represented
disease in the right coronary artery and lateral defects repre-
sented disease in the left circumflex artery. Because of the
variation of blood supply to the apex, the apex was not used for
coronary artery assignment. However, pure apical defects were
considered as one abnormal coronary territory but were not
assigned to any specific coronary territory. The presence of only
one abnormal coronary territory was defined as a reversible or
fixed perfusion defect that occurred in one vascular territory. In
the presence of overlap between coronary territories, minimal
extension of a perfusion defect into the adjacent territory was
considered as a perfusion defect of the predominant territory.
This ambiguity was confined to septal segments where the
arterial supply is variable. If both septal segments were abnor-
mal, the patient was still classified as having one abnormal
territory if only one of the two contiguous segments (anterior
or inferior) was also abnormal.
Coronary angiography. All patients in the training popu-
lation underwent coronary angiography within six months
of thallium imaging (median time, 1 day; range, 177 days
Table 1. Comparison Between Patients in the Training Population and the
Validation Population
Variables
Population
p Value*
Training
(n 5 264)
Validation
(n 5 474)
Clinical
Age (yrs) 62 6 10 62 6 11 NS
Gender (male) 215 (81%) 364 (77%) NS
Current cigarette smoking 106 (40%) 158 (35%) NS
Diabetes 36 (14%) 67 (14%) NS
Hypertension 117 (44%) 237 (50%) NS
Untreated 25 (22%) 43 (18%) NS
Hypercholesterolemia 131 (50%) 209 (44%) NS
Typical angina 92 (35%) 106 (22%) , 0.001
Previous MI 97 (37%) 163 (34%) NS
Family history of CAD 127 (48%) 194 (41%) NS
Drugs:
Beta-blockers 103 (39%) 155 (33%) NS
Calcium channel blockers 129 (49%) 178 (38%) 0.003
Long-acting nitrates 100 (38%) 123 (26%) , 0.001
Exercise protocol:
Bruce 210 (80%) 411 (87%) 0.01
Naughton 54 (20%) 54 (11%) , 0.001
Peak heart rate (beats/min) 124 6 25 133 6 24 , 0.001
Peak HR 3 BP 21,066 6 6456 23,566 6 6,039 , 0.001
Change of systolic BP (mm Hg) 34 6 25 40 6 23 0.001
Duration (METs) 7.5 6 2.4 7.9 6 2.5 0.02
ST depression $1 mm 127 (48%) 168 (35%) , 0.001
Exercise chest pain 85 (32%) 85 (17%) , 0.001
Thallium
Cardiac enlargement 59 (22%) 95 (20%) NS
Increased lung uptake 40 (15%) 49 (10%) NS
No. of abn post-stress seg† 5 6 2 4 6 3 , 0.001
Anterior defect 107 (41%) 138 (29%) 0.002
*p Value of training versus validation population. †Number of abnormal post-stress segments.
MI 5 myocardial infarction; CAD 5 coronary artery disease; BP 5 blood pressure; peak HR 3 BP 5 peak rate-pressure
product; METs 5 metabolic equivalents. Data presented are mean value 6 SD or number of patients with percentage.
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before to 167 days after). Coronary artery narrowing was
visually assessed and reported as percentage luminal diam-
eter stenosis. Significant coronary stenosis was defined as
$70% narrowing of the internal diameter of the left anterior
descending artery the left circumflex artery, the right coro-
nary artery, or their major branches; and $50% narrowing
of the left main coronary artery (12). Additionally, an
angiographic jeopardy score was calculated for each patient
using two prognostically validated scoring methods (Califf
et al. [18], and Mark et al. [19]). These systems have shown
increased five-year event rates (18) and greater survival
benefit from coronary revascularization surgery (19) for
patients with higher scores.
Follow-up procedure. The study was designed so that
follow-up was not initiated until at least five years from the
thallium stress test. Consequently, patients with follow-up
under five years represent those with events qualifying as an
end point or a censoring criteria. The validation population
was followed by mailed questionnaire, telephone interview
or review of the patient’s medical record or physician
contact. Events were defined as death, cardiac death, myo-
cardial infarction (MI) and late revascularization (.90 days
from study). Death was confirmed by reviewing the hospital
chart, a death certificate or a clinician’s report. The cause of
death of each patient was coded as cardiac or noncardiac by
a reviewer blinded to the baseline information and the
exercise thallium results. Myocardial infarction was defined
on the basis of chest pain, electrocardiographic (ECG)
changes and elevated serum creatine kinase or isoenzyme
levels. Revascularization included PTCA or CABG.
Statistics. The Student t test or chi-square test for inde-
pendence was performed to identify variables significantly
associated with 3VLMD for the training population, all of
whom were referred for coronary angiography (a p value
,0.05 was considered significant). Variables considered for
this analysis are shown in Table 1. Logistic regression
analysis was used to develop a multivariate model for
predicting the presence or absence of 3VLMD. All variables
from Table 1 were considered for stepwise inclusion in the
model until variables not entered into the model were not
significant at the p , 0.10 level. The regression model was
then utilized to estimate the probability of 3VLMD for each
patient by classifying them as low (,15%), intermediate
(15% to 35%) and high (.35%) probability. These proba-
bility groupings were chosen prospectively to match prior
studies for the noninvasive prediction of 3VLMD from this
laboratory (8,20,21). We then applied the multivariate
model developed from the training population to the vali-
dation population. Each patient from this group was placed
into a risk group in an identical manner as with the training
cohort. This approach assumes that patients predicted to be
at higher risk for 3VLMD (and higher jeopardy scores) will
have a higher event rate than those predicted to be at lower
risk for 3VLMD.
Four end points were analyzed, and the Kaplan-Meier
method was used to estimate event-free survival. Three
survival curves (for high-, intermediate-, and low-risk pa-
tients) were generated for each of the four end points: 1)
overall survival (no patients censored from analysis); 2)
survival free of cardiac death (censoring of patients with
noncardiac death or PTCA/CABG at any time after exer-
cise testing); 3) survival free of cardiac death and nonfatal
MI (censoring of patients with noncardiac death or PTCA/
CABG at any time after exercise testing); 4) survival free of
cardiac death, nonfatal MI and late revascularization (cen-
soring of patients with noncardiac death or early PTCA/
CABG). The log-rank test was used to compare each set of
curves.
RESULTS
Comparison of the training and validation populations
by univariate analysis. Clinical characteristics, exercise
variables and thallium variables of the two populations are
shown in Table 1. The training population was a slightly
“sicker” cohort; they had a higher prevalence of typical
angina, a worse exercise performance (a lower peak exercise
heart rate, peak exercise rate-pressure product and exercise
workload) and a higher prevalence of exercise-induced chest
pain and exercise-induced ST-segment depression of
.1 mm. There were similar proportions of patients in the
training and validation groups with cardiac enlargement or
elevated pulmonary uptake. The mean total number of
abnormal post-stress thallium segments was five in the
training group and four in the validation group (p , 0.001).
A higher proportion of patients in the training population
had a left anterior descending artery territory defect. An
isolated apical defect was present in none of the training
population patients and 56 (12%) of the validation popula-
tion.
Training population (development of the model).
ANGIOGRAPHIC RESULTS. Overall, 68 patients (26%) had
3VLMD. Five patients had isolated left main disease, 49
Figure 1. Short-axis tomographic segments in relation to coronary
territories. The left anterior descending artery (LAD) supplies
anterior and anteroseptal walls; the right coronary artery (RCA)
supplies inferior and inferoseptal walls; the left circumflex artery
(LCx) supplies lateral wall. (See text.)
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patients had three-vessel but not left main disease, 14
patients had both three-vessel and left main disease. The
majority of left main lesions (14/19) were between 50% to
70% luminal obstruction. The prevalence of two-vessel,
single-vessel and no disease were 30%, 27% and 17%,
respectively. The median Califf jeopardy score was 4 and the
median Mark score was 32.
UNIVARIATE ANALYSIS. The results of the univariate analy-
sis for clinical, exercise and thallium variables are shown in
Table 2. Significant differences existed in multiple clinical
and exercise variables between patients with 3VLMD and
without. Patients with 3VLMD had a significantly higher
prevalence of diabetes, hypertension and history of typical
angina. During exercise, patients with 3VLMD had a
higher prevalence of ST-segment depression, achieved a
lower peak heart rate, a lower peak rate-pressure product
and a smaller increase in systolic blood pressure. Cardiac
enlargement and pulmonary/myocardial count ratio were
not associated with 3VLMD. The presence of an anterior
defect and the number of abnormal post-stress segments (a
measure of defect extent) did not help to identify patients
with 3VLMD.
MULTIVARIATE ANALYSIS. A multivariate logistic regression
analysis was employed to develop a model for the prediction
of 3VLMD based upon the clinical, exercise and thallium
variables listed in Table 3. The magnitude levels of exercise-
induced ST depression, peak rate-pressure product, diabetes
and hypertension were the only independent predictors of
3VLMD in patients with one abnormal coronary territory
by exercise thallium-201 imaging. No thallium scintigraphic
variables, including cardiac enlargement, elevated pulmo-
nary uptake, number of hypoperfused segments, anterior
location, or presence of defect reversibility, added indepen-
dently for the prediction of severe CAD in this cohort. The
overall chi-square value of the model was 23.7 and the
individual chi-square values are listed in Table 3.
Table 2. Univariate Analysis of Clinical, Exercise and Thallium Variables to Identify Predictors
of 3VLMD in the Training Population
Variables
Left Main or Three-Vessel Disease
p Value
Present
(n 5 68)
Absent
(n 5 196)
Clinical
Age (yrs) 63 6 8 61 6 11 NS
Gender (male) 58 (85%) 157 (80%) NS
Current cigarette smoking 24 (35%) 82 (42%) NS
Diabetes 16 (24%) 20 (10%) 0.018
Hypertension 37 (54%) 80 (41%) 0.052
Hypercholesterolemia 33 (49%) 98 (50%) NS
Typical angina 36 (53%) 56 (29%) 0.001
Previous MI 27 (40%) 70 (36%) NS
Family history of CAD 34 (50%) 93 (47%) NS
Drugs:
Beta-blockers 26 (38%) 77 (39%) NS
Calcium channel blockers 37 (54%) 92 (47%) NS
Long-acting nitrates 26 (38%) 74 (38%) NS
Exercise protocol:
Bruce 55 (81%) 155 (79%) NS
Naughton 13 (19%) 41 (21%) NS
Peak heart rate (beats/min) 119 6 27 126 6 24 0.019
Peak HR 3 BP 19,474 6 6,644 21,618 6 6,313 0.014
Change in peak systolic BP (mm Hg) 27 6 27 36 6 23 0.037
ST depression $1 mm 42 (62%) 85 (43%) 0.009
Duration (METs) 7.3 6 2.4 7.6 6 2.3 NS
Exercise chest pain 27 (40%) 58 (30%) NS
Thallium
Cardiac enlargement 18 (26%) 41 (21%) NS
Increased lung uptake 9 (13%) 31 (16%) NS
Number of abn post-stress seg 5 6 3 4 6 2 NS
Anterior defect 21 (31%) 86 (44%) NS
Angiographic Jeopardy Score
Califf et al. (18) median (range) 6 (0–12) 2 (0–8) 0.001
Mark et al. (19) 56 (2–82) 32 (0–63) 0.001
Abbreviations are the same as those of Table 2.
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RISK STRATIFICATION FOR THE TRAINING POPULATION. A
predicted probability for 3VLMD was calculated for each
patient by the regression equation derived from the multi-
variate model. Patients were then placed into risk groups
defined as low (,15%), intermediate- (15 to 35%) and high
probability (.35%) for 3VLMD. The prevalence of
3VLMD in low-, intermediate-, and high-risk groups was
15%, 22% and 51%, respectively (Table 4). Consequently,
.50% of patients defined as high-risk actually had 3VLMD
despite one abnormal thallium territory. The angiographic
jeopardy scores by the Califf method (18) and Mark method
(19) demonstrated a monotonic increase as the risk of severe
CAD increased, which was highly significant.
To express the predictive value of this model in a
clinically usable format, nomograms based on the variables
from the model were generated to estimate the risk of
3VLMD in individual patients (Fig. 2). Based on the
absence or presence of diabetes and hypertension, patients
can be classified into four categories: those who have neither
diabetes nor hypertension, those who have diabetes alone,
those who have hypertension alone and those who have
both diabetes and hypertension. The probability of
3VLMD for each patient can be estimated by applying the
exercise variables—magnitude of maximum ST segment
depression and rate-pressure product. For example, a nor-
motensive, nondiabetic patient with one abnormal thallium
coronary territory who has a rate-pressure product of 25,000
and ,1 mm ST depression is at low risk to have 3VLMD.
A patient with both diabetes and hypertension is automat-
ically classified as at least intermediate risk.
Validation population (testing of the model). The valid-
ity of these independent predictors to detect severe disease
was tested in the validation population to predict outcome.
Follow-up was initiated at least five years from the exercise
study. The median follow-up period was seven years, with a
range of 19 days (reflecting early events or censoring) to 11.5
years, and was 95% complete. Twenty-three patients were
lost to follow-up, and two patients excluded during
follow-up because of missing peak exercise data. As a result,
449 patients qualified for survival analysis. Using the mul-
tivariate model derived from the training population, each
patient in the validation population was classified into low-,
intermediate-, or high-risk group for 3VLMD. The out-
come of the patients by risk group are shown in Table 5.
Figure 3 shows the Kaplan-Meier survival curves of 1)
overall survival; 2) survival free of cardiac death; 3) survival
free of cardiac death and nonfatal MI; and 4) survival free of
cardiac death, nonfatal MI and late revascularization. The
survival curves for the validation population demonstrate a
significant association between risk stratification by the
multivariate model (based upon angiographic results) and
subsequent outcome in patients with one abnormal coronary
perfusion territory on exercise thallium-201 imaging with
the exception of the end point of cardiac death or MI. The
eight-year overall survival rates in the low-, intermediate-
and high-risk group patients were 89%, 73% and 75%,
respectively (p , 0.001). The eight-year survival free of
cardiac death, and cardiac death, MI or late revasculariza-
tion also had significantly divergent outcomes based upon
risk stratification from the model derived from the angio-
graphic cohort (Fig. 3A–D).
DISCUSSION
Identification of 3VLMD by perfusion scintigraphy.
Although the sensitivity of exercise thallium myocardial
perfusion imaging for detecting CAD in patients with
severe disease is excellent, only a minority of patients with
three-vessel CAD have perfusion defects in all three coro-
nary territories. Christian et al. (8) reported that only 29% of
patients with three-vessel CAD had perfusion defects in all
three coronary territories. Iskandrian et al. (11) showed that
39% of patients with three-vessel CAD had perfusion
defects in all three coronary territories by exercise thallium
imaging if they achieved an adequate exercise level.
For several reasons, we chose to study the scenario of
patients with one abnormal territory and severe CAD. The
prevalence of severe CAD with this finding is not low (26%
in this study), whereas it is uncommon in patients with
normal images (,4% of patients referred to angiography
[8]). Patients with multiterritory defects are more likely to
Table 3. Multivariate Analysis for Independent Predictors of
3VLMD in the Training Population
Independent Predictors of
3VLMD x2 Coefficient
p
Value
Magnitude of ST depression 9.78 0.32 0.002
Rate-pressure product 7.62 20.00007 0.006
Diabetes 4.37 0.5633 0.037
Hypertension 2.77 0.5066 0.096
Table 4. Angiographic Results by Risk Classification From Model
Angiographic Scoring Method
Low Risk
(n 5 61)
Intermediate Risk
(n 5 152)
High Risk
(n 5 51) p Value
%3VLMD CASS criteria (12) 15% 22% 51% , 0.001
Califf Jeopardy median score
(range) (18)
2 (0–6) 4 (0–12) 6 (0–12) , 0.001
Mark Prognostic median score
(range) (19)
23 (0–63) 32 (0–83) 42 (0–83) , 0.001
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be referred to angiography; patients with one abnormal
territory may be medically managed on the presumption of
single-vessel disease. This strategy may be appropriate for
the majority of patients, but a cohort will be missed where
revascularization has been shown to alter prognosis (12–15).
The present study was designed to detect those patients.
Identification of 3VLMD and prediction of outcome in
this study. Because patients with 3VLMD have a higher
cardiac event rate, we attempted to validate a multivariate
model for predicting 3VLMD (derived from the angio-
graphic cohort) by prospectively applying it to a separate,
unbiased cohort of patients with one abnormal coronary
territory for the prediction of outcome. The prevalence of
3VLMD in the angiographic cohort ranged from 15% in
the low-risk group to 51% in the high-risk group, and the
jeopardy scores increased as the predicted risk of severe
CAD increased. Patients with a Califf jeopardy score of 6
(the median value in the high-risk group) have an event rate
fivefold greater than do patients with a score of 2 (the
median value in the low-risk group) (18).
Patients in the validation population were stratified into risk
groups by the training model. Significant differences existed
between the low-risk group and the intermediate and high-risk
groups in terms of 1) overall survival, 2) survival free of cardiac
death and 3) survival free of cardiac death, nonfatal MI, or late
revascularization. However, it should be emphasized that the
overall prognosis in this cohort was good, consistent with the
limited extent of scintigraphic ischemia defined by this study.
There were few cardiac deaths and MIs (8% and 3% of the
validation population, respectively). Consequently, no signifi-
cant difference was seen among the three risk groups concern-
ing survival free of cardiac death or nonfatal MI. This lack of
a significant difference may be related to the subsequent
occurrence of nonfatal MI as a result of plaque rupture of
Figure 2. Estimated probability of 3VLMD for patients with (A) no history of diabetes or hypertension, (B) hypertension, (C) diabetes,
(D) both diabetes and hypertension. Zones of different probability are shown. (See text for details.)
Table 5. Risk Stratification of the Validation Population
Risk Group n
Patient Events
Death* Cardiac Death MI Revascularization†
Low 150 18 (12%) 6 (4%) 7 (5%) 16 (11%)
Intermediate 248 69 (28%) 25 (10%) 7 (3%) 39 (16%)
High 51 12 (24%) 3 (6%) 0 (0%) 14 (27%)
Total 449 99 (22%) 34 (8%) 14 (3%) 69 (15%)
*Cardiac and noncardiac death. †Late revascularization.
MI 5 nonfatal myocardial infarction.
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coronary lesions of ,50% in diameter, which may not be
detected by perfusion imaging, as well as the limited number of
such events.
Parameters such as perfusion defect extent, which have
been strong predictors of outcome in multiple prior studies,
were constrained in range by the exclusion of patients with
more than one abnormal territory. Consequently, they did
not add significantly to the model for the prediction of
3VLMD in the training population as might have been
expected. The high degree of random variability of multi-
variate models when constructed from different populations
has been well described (22). Consequently, we did not
pursue a “better fit” multivariate model to predict outcome
in this group. Interestingly, neither cardiac enlargement nor
increased pulmonary thallium-201 uptake was predictive of
3VLMD in the angiographic cohort. Prior studies employ-
ing tomographic imaging (including this laboratory) have
shown these variables to be a univariate predictor of severe
CAD but not an independent predictor once other measures
of ischemia are adjusted for (8,11). This may be due to the
constraint on the extent of ischemia required by this study.
Previous studies for the detection of 3VLMD by exercise
thallium imaging. The evidence that clinical and exercise
variables used in conjunction with stress thallium scintigra-
phy improve accuracy for the prediction of 3VLMD is
strong (4–10). Maddahi et al. (4) reported that quantitative
thallium stress distribution and washout, or exercise hypo-
tension response, or marked stress electrocardiographic
response, detected 86% of patients with 3VLMD by planar
thallium study. Christian et al. (8) concluded that magni-
tude of ST depression with exercise is the most important
independent predictor of 3VLMD, followed by the number
of abnormal thallium segments, diabetes and the change in
systolic blood pressure with exercise. Iskandrian et al. (9)
found that the most important independent predictor of
3VLMD was a multivessel thallium abnormality, but exer-
cise heart rate and ST-segment depression were also inde-
pendent predictors. In patients with normal resting ECGs,
the incremental value of thallium imaging for predicting
3VLMD over clinical and exercise variables is minimal (20).
This study supports and extends previous observations
that the clinical and exercise variables are useful for the
prediction 3VLMD and outcome (23–25). Mark et al. (26)
emphasized the importance of combining test variables to
strengthen the overall predictive value of exercise treadmill
testing. The present study reaffirms the value of such an
approach for exercise perfusion imaging when applied to
specific conditions.
Figure 3. Actuarial event-free survival curves based on (A) overall survival, (B) survival free of cardiac death, (C) survival free of cardiac
death and nonfatal myocardial infarction, and (D) survival free of cardiac death, nonfatal myocardial infarction, and late revascularization,
of the validation population stratified by the multivariate model into low (,15%), intermediate (15% to 35%), and high (.35%) probability
groups. Numbers below abscissa 5 numbers of patients available for analysis at each time point. (See text for details.)
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One abnormal thallium coronary territory with 3VLMD.
Several potential mechanisms explain the presence of only
one abnormal perfusion coronary territory in the setting of
3VLMD. First, exercise may be stopped owing to a single
severe lesion producing symptoms or signs necessitating test
termination. While thallium perfusion imaging measures
flow heterogeneity, the relative decrease of coronary blood
flow in the other diseased vessels may be insufficient at that
point to produce a perfusion defect. This is evident by
pooled data showing that only 69% of the diseased vessels
can be detected in patients with three-vessel disease, as
compared to 83% of the diseased vessels in patients with
single-vessel disease (27). The sensitivity for detection of
disease in an individual coronary artery differs, particularly
in the left circumflex territory where the detection of disease
is reduced compared to the other two regions (28). This may
be partially responsible for producing a single abnormal
territory in the setting of moderate left main disease.
Relative hypoperfusion of myocardium can be well appre-
ciated by thallium scintigraphy. Nevertheless, in patients
with three-vessel disease, the two less ischemic coronary
territories may have a similar degree of impaired flow
reserve, resulting in apparently only one abnormal thallium
coronary territory despite three-vessel disease.
The number of abnormal post-stress perfusion segments
tended to be higher in patients with 3VLMD, but the
difference was not significant. This was likely due to the
constraints on the extent of abnormal segments dictated by
the study design. Additionally, there was a somewhat higher
proportion of patients with anterior defects in the non-
3VLMD group, which often involves the apex (an addi-
tional four abnormal segments), as opposed to nonanterior
defects.
Study limitations. This study was performed at a tertiary
referral center. Consequently, the prevalence of severe
coronary artery disease was likely to be higher than that in
community-based hospitals. To identify the ability of a
noninvasive test to predict 3VLMD, the model was devel-
oped on a test group of patients who all underwent coronary
angiography. This posttest referral bias was unavoidable. It
was for this reason that we applied the results of the
angiographic population to an independent population,
which was less selected but also “less sick.” Although there
is some inherent inaccuracy in this approach in comparison
to applying the model to an unselected population of
patients randomized to undergo coronary angiography, it is
preferable to no validation procedure. The limitations of
using coronary angiography (which reflects anatomical se-
verity of CAD) as the gold standard for comparison with
perfusion scintigraphy (which reflects functional coronary
perfusion) are well recognized (29).
Transient ischemic dilation, which is an independent
determinant of prognosis and is associated with 3VLMD,
was not routinely assessed in our patients. Washout rate
quantitation, which may have helped to identify more severe
disease, was not employed owing to the use of tomographic
acquisition techniques. We did not consider mild fixed
defects as constituting an abnormal territory as the vast
majority of these represent attenuation artifacts. However,
there is evidence that the event rate in patients with mild
scintigraphic abnormalities (without gated imaging) is in-
creased compared to those with clearly normal scans (30).
Multiple variables were considered for the generation of the
multivariate model for the prediction of 3VLMD, which
might result in some “overfitting” of the model, but appli-
cation to an independent patient cohort minimizes the
impact of this phenomenon.
Conclusions. Patients with one-vessel coronary artery dis-
ease generally have an excellent prognosis, with an annual
mortality rate of approximately 1% (19). A substantial
minority of patients with only one abnormal thallium
territory have 3VLMD, and they have divergent prognoses.
Patients with one abnormal coronary territory should not be
presumed to have single-vessel disease and, therefore, a
benign clinical outcome. For low-risk patients, the preva-
lence of 3VLMD was low and mortality was comparable to
that of patients with angiographically demonstrated single-
vessel disease (13). Therefore, the clinical decision to refer a
patient from the low-risk group to coronary angiography
should be based primarily on the patient’s symptoms.
In contrast, intermediate- and high-risk patients have a
considerable prevalence of 3VLMD, and a higher mortality.
Coronary angiography should be considered in such pa-
tients. The use of gating of the tomographic images for
regional wall motion, which is becoming a common prac-
tice, may provide superior identification of patients with
3VLMD by resolving the etiology of mild fixed defects.
This possibility needs to be explored.
Reprint requests and correspondence: Dr. Timothy F. Chris-
tian, Mayo Clinic E-16B, 200 First Street SW, Rochester,
Minnesota 55902.
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